BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Evolent Health Announces Second Quarter 2018 Results

  Evolent Health, Inc. announced financial results for the quarter ended June 30, 2018.

  August 7, 2018

   · 

  76 min read
• Business

  22nd Century Files 2018 Second Quarter Report

  Company significantly increases spending and strategic initiatives in support of MRTP application and FDA’s ANPRM for reduced nicotine cigarettes.

  August 7, 2018

   · 

  16 min read
• Policy

  AHF Urges G20 Countries to Do More on Global Public Health

  Under Argentina’s Presidency of the G20, leading economies in Latin America need to step up their contributions to fight against global AIDS and other related public-health threats

  August 7, 2018

   · 

  8 min read
• Business

  Neuralstem Appoints Jim Scully as Interim Chief Executive Officer

  Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, today announced that the Board of Directors has appointed Jim Scully as interim chief executive officer.

  August 7, 2018

   · 

  4 min read
• Business

  Denali Therapeutics Appoints Dana Andersen, Ph.D., as Chief Technical and Manufacturing Officer

  Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today announced that Dr. Dana Andersen has joined the company as Chief Technical and Manufacturing Officer.

  August 7, 2018

   · 

  1 min read
• Business

  Myovant Provides Corporate Update and Reports Financial Results for First Fiscal Quarter Ended June 30, 2018

  Completed patient screening for Phase 3 LIBERTY 1 Trial

  August 7, 2018

   · 

  15 min read
• Business

  Merck’s Head of Human Resources Mirian M. Graddick-Weir to Retire; Steven C. Mizell Will Assume Role on Oct. 1

  Merck announced the retirement effective November 30, 2018 of its chief human resources officer Mirian M. Graddick-Weir, following 12 years of service with the company.

  August 7, 2018

   · 

  5 min read
• Business

  InVivo Therapeutics Reports 2018 Second Quarter Financial Results

  Significant Increase in Operating Efficiency; Operating Expenses Decreased by 59%

  August 7, 2018

   · 

  7 min read
• Business

  Invacare Reports Results for Second Quarter 2018

  Invacare Corporation reported results for the quarter ended June 30, 2018.

  August 7, 2018

   · 

  26 min read
• Business

  Medpace Holdings, Inc. Announces Secondary Offering of 4,500,000 Shares of Common Stock by Selling Shareholder

  Medpace Holdings, Inc. announced a secondary offering of 4,500,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited

  August 7, 2018

   · 

  2 min read